Testicular cancer

L Cheng, P Albers, DM Berney, DR Feldman… - Nature Reviews …, 2018 - nature.com
Testicular cancer is the most common malignancy among men between 14 and 44 years of
age, and its incidence has risen over the past two decades in Western countries. Both …

Male reproductive disorders and fertility trends: influences of environment and genetic susceptibility

NE Skakkebaek, E Rajpert-De Meyts… - Physiological …, 2016 - journals.physiology.org
It is predicted that Japan and European Union will soon experience appreciable decreases
in their populations due to persistently low total fertility rates (TFR) below replacement level …

Diagnosis and treatment of early stage testicular cancer: AUA guideline

A Stephenson, SE Eggener, EB Bass… - The Journal of …, 2019 - auajournals.org
Purpose: Testis cancer is the most common solid malignancy in young males. The purpose
of this guideline is to provide a useful reference on the effective evidence-based treatment of …

Non-epithelial ovarian cancers: how much do we really know?

A Cheung, S Shah, J Parker, P Soor, A Limbu… - International journal of …, 2022 - mdpi.com
Non-epithelial ovarian cancers (NEOC) are a group of uncommon malignancies that mainly
includes germ cell tumours (GCT), sex cord-stromal tumours (SCST), and some extremely …

What is trophoblast? A combination of criteria define human first-trimester trophoblast

CQE Lee, L Gardner, M Turco, N Zhao, MJ Murray… - Stem cell reports, 2016 - cell.com
Controversy surrounds reports describing the derivation of human trophoblast cells from
placentas and embryonic stem cells (ESC), partly due to the difficulty in identifying markers …

[HTML][HTML] Circulating MicroRNAs, the next-generation serum biomarkers in testicular germ cell tumours: a systematic review

R Leao, M Albersen, LHJ Looijenga, T Tandstad… - European urology, 2021 - Elsevier
Context Clinical management of testicular germ cell tumours (GCTs) is hampered by low
sensitivity and specificity of the biomarkers currently in use. Circulating microRNAs (miRs) …

[HTML][HTML] Serum levels of microRNA miR-371a-3p: a sensitive and specific new biomarker for germ cell tumours

KP Dieckmann, A Radtke, M Spiekermann, T Balks… - European urology, 2017 - Elsevier
Background Clinical management of germ cell tumours (GCTs) relies on monitoring of
serum tumour markers. However, the markers α-fetoprotein (AFP), the β-subunit of human …

Consensus on the management of intracranial germ-cell tumours

MJ Murray, U Bartels, R Nishikawa… - The Lancet …, 2015 - thelancet.com
The management of intracranial germ-cell tumours is complex because of varied clinical
presentations, tumour sites, treatments and outcomes, and the need for multidisciplinary …

Human germ cell tumors are developmental cancers: impact of epigenetics on pathobiology and clinic

J Lobo, AJM Gillis, C Jerónimo, R Henrique… - International journal of …, 2019 - mdpi.com
Current (high throughput omics-based) data support the model that human (malignant) germ
cell tumors are not initiated by somatic mutations, but, instead through a defined locked …

Pregnancy-associated miRNA-clusters

DM Morales-Prieto, S Ospina-Prieto… - Journal of reproductive …, 2013 - Elsevier
MicroRNAs (miRNAs) are expressed in the placenta and can be detected in maternal
plasma. An increasing number of studies have been published on the cellular origin …